U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C19H25N5O5
Molecular Weight 403.4323
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALFUZOSIN LACTONE

SMILES

COC1=CC2=NC(=NC(N)=C2C=C1OC)N(C)CCCNC(=O)C3CCC(=O)O3

InChI

InChIKey=OLMWCJZINHWWNW-UHFFFAOYSA-N
InChI=1S/C19H25N5O5/c1-24(8-4-7-21-18(26)13-5-6-16(25)29-13)19-22-12-10-15(28-3)14(27-2)9-11(12)17(20)23-19/h9-10,13H,4-8H2,1-3H3,(H,21,26)(H2,20,22,23)

HIDE SMILES / InChI

Approval Year

Name Type Language
ALFUZOSIN LACTONE
Common Name English
SL80.0306
Common Name English
N-(3-((4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)METHYLAMINO)PROPYL)TETRAHYDRO-5-OXO-2-FURANCARBOXAMIDE
Systematic Name English
2-FURANCARBOXAMIDE, N-(3-((4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)METHYLAMINO)PROPYL)TETRAHYDRO-5-OXO-
Systematic Name English
SL 80.0306
Common Name English
ALFUZOSIN METABOLITE SL80.0306
Common Name English
Code System Code Type Description
FDA UNII
18FS87G8N6
Created by admin on Sat Dec 16 15:40:33 GMT 2023 , Edited by admin on Sat Dec 16 15:40:33 GMT 2023
PRIMARY
PUBCHEM
146014899
Created by admin on Sat Dec 16 15:40:33 GMT 2023 , Edited by admin on Sat Dec 16 15:40:33 GMT 2023
PRIMARY
CAS
101986-74-7
Created by admin on Sat Dec 16 15:40:33 GMT 2023 , Edited by admin on Sat Dec 16 15:40:33 GMT 2023
PRIMARY
EPA CompTox
DTXSID001114878
Created by admin on Sat Dec 16 15:40:33 GMT 2023 , Edited by admin on Sat Dec 16 15:40:33 GMT 2023
PRIMARY